Get In Touch

Thoracic outlet syndrome (TOC) is a group of disorders that cause pain in the neck, shoulder, and arms and numbness and tingling of the fingers. The thoracic outlet syndrome is caused by the compression of blood vessels and nerves in the space between the collarbone and the first rib known as thoracic outlet. The common causes of thoracic outlet syndrome include damage to the shoulder or neck, injuries caused because of sports-related activities, anatomical defects, tumors in chest, and obesity. There are three types of thoracic outlet syndromes: neurogenic, vascular, and non-specific. Treatment for thoracic outlet syndrome includes therapeutic drugs such as anti-inflammatory drugs, anti-coagulation drugs, and muscle relaxants. When medicinal therapy does not improve the symptoms of thoracic outlet syndrome, surgical treatments are performed to relive them.

The global thoracic outlet syndrome treatment market is projected to be primarily driven by rise in incidence of thoracic outlet syndrome across the globe. It is estimated that around 8% of total population in the U.S. is affected by thoracic outlet syndrome. Women are more likely to be affected by thoracic outlet syndrome than men. Easy availability of diagnostics tools such as MRI and CT scan for detecting conditions such as presence of tumors and aneurysms causing nerve contraction, X-ray screening,  electromyography (EMG), and nerve conduction study are likely to drive the expansion of the thoracic outlet syndrome treatment market. However, availability of alternative treatment methods such as physiotherapy treatment and home remedy treatment are likely to restrain the market.

The global thoracic outlet syndrome treatment market can be segmented based on type, drug class, distribution channel, and geography. In terms of type, the global thoracic outlet syndrome market can be categorized into neurogenic, vascular, and non-specific. Out of the three type of thoracic outlet syndromes, neurogenic is the most common type. More than 95% cases of reported thoracic outlet syndrome cases are neurogenic. Neurogenic thoracic outlet syndrome is characterized by the compression of the brachial plexus. In vascular thoracic outlet syndrome, one or more of the veins and arteries under the collarbone are compressed.  In terms of drugs class, the global thoracic outlet syndrome market can be divided into non-steroidal anti-inflammatory drugs (NSAID), skeletal muscle relaxants, anticoagulants, and botulinum toxin therapeutics. The NSAID drugs segment is projected to hold a prominent share of the global thoracic outlet syndrome treatment market owing to increased usage of NSAID drugs as the first line of treatment for thoracic outlet syndrome. NSAIDs are anti-inflammatory drugs used for controlling inflammation, pain, and fever. NSAID drugs are easily available over the counter and are non-prescription drugs for the management of inflammation caused due to thoracic outlet syndrome. Ibuprofen is the most commonly used NSAID for the management of thoracic outlet syndrome. In botulinum toxin therapy, small amounts of botox is injected into muscle located in the neck. Anticoagulant drugs are used for dissolving blood clots present in arteries or veins. In terms of distribution channel, the global thoracic outlet syndrome market can be segmented into hospital pharmacy, retail pharmacy, and online pharmacy store.

Based on geography, the global thoracic outlet syndrome therapy market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for a significant share of the global market owing to easy availability of NSAID drugs, rapidly growing elderly population, and well-established health care facilities in the region. Europe is projected to constitute a key share holder of global thoracic outlet syndrome treatment market by the end of 2026. The market in Asia Pacific is expedted to expand at a significant CAGR during the forecast period owing rapidly increasing number of patients with thoracic outlet syndrome in China, India, and Japan, changing health care infrastructure in the region, and easy availability of therapeutic drugs.

The global thoracic outlet syndrome market is highly fragmented with a large number of manufacturers holding prominent share in different regions. Key players operating in the global thoracic outlet syndrome market include Pfizer Inc., Mylan N.V., F. Hoffmann-La Roche AG, Novartis AG, Allergan plc., Piramal Critical Care, Inc., Apotex Inc., Shire Plc, and Validus Pharmaceuticals LLC..

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Thoracic Outlet Syndrome Treatment Market

Pre Book